Cochrane Abstracts
Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Natalizumab for Relapsing Remitting Multiple Sclerosis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433544/all/Natalizumab_for_relapsing_remitting_multiple_sclerosis:_Cochrane_systematic_review. Accessed 28 November 2023.
Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433544/all/Natalizumab_for_relapsing_remitting_multiple_sclerosis:_Cochrane_systematic_review. Accessed November 28, 2023.
Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433544/all/Natalizumab_for_relapsing_remitting_multiple_sclerosis:_Cochrane_systematic_review
Natalizumab for Relapsing Remitting Multiple Sclerosis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2023 November 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433544/all/Natalizumab_for_relapsing_remitting_multiple_sclerosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
ID - 433544
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433544/all/Natalizumab_for_relapsing_remitting_multiple_sclerosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
